# A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

> **NCT01718093** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 21 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Metformin
- **DRUG:** Sitagliptin + Metformin

## Key facts

- **NCT ID:** NCT01718093
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718093, "A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01718093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*